KEGG: ecj:JW1965
STRING: 316385.ECDH10B_2129
The yeeO protein (UniProt P76352) is a putative transport protein found in Escherichia coli (strain K12). It functions as part of bacterial membrane transport systems. yeeO antibodies are essential tools for studying bacterial membrane physiology, transport mechanisms, and potential antimicrobial targets in E. coli research . These antibodies enable researchers to detect, quantify, and isolate this protein in various experimental contexts, making them valuable for fundamental bacterial physiology studies.
Commercial yeeO antibodies (such as CSB-PA304347XA01ENV) are typically polyclonal antibodies raised in rabbits against recombinant E. coli (strain K12) yeeO protein. They have the following specifications:
| Specification | Details |
|---|---|
| Type | Polyclonal |
| Host | Rabbit |
| Reactivity | Escherichia coli (strain K12) |
| Applications | ELISA, Western Blot |
| Form | Liquid |
| Storage Buffer | 50% Glycerol, 0.01M PBS, pH 7.4, 0.03% Proclin 300 |
| Purification | Antigen Affinity Purified |
| Isotype | IgG |
| Storage | -20°C or -80°C, avoid repeated freeze-thaw cycles |
These specifications are critical for experimental planning and interpretation of results .
Proper validation of yeeO antibody specificity requires a systematic approach comparing wild-type (WT) and knockout (KO) systems:
Generate yeeO gene knockout E. coli strains using CRISPR/Cas9 or other gene editing methods
Compare antibody signals between WT and KO samples using multiple detection methods:
Western blot: A specific antibody will show strong signal in WT and no signal in KO
Immunofluorescence: Image both WT and KO cells in the same field to reduce bias
Flow cytometry: Label WT and KO cells with different fluorescent dyes and combine at 1:1 ratio
This comparative approach follows established validation principles for ensuring antibody specificity, as demonstrated in similar bacterial protein studies .
Optimizing Western blot protocols for yeeO antibodies requires systematic adjustment of several parameters:
| Parameter | Optimization Approach |
|---|---|
| Blocking | Test different agents (BSA, milk, commercial blockers) at varying concentrations (1-5%) |
| Antibody dilution | Begin with manufacturer's recommendation (typically 1:500-1:2000) and titrate |
| Incubation conditions | Compare 4°C overnight vs. room temperature for 1-2 hours |
| Washing | Optimize buffer composition, number of washes (3-6), and duration (5-15 min) |
| Detection system | Compare chemiluminescence, fluorescence, or colorimetric methods |
| Sample preparation | Test different lysis buffers and protein loading amounts |
Always include positive controls (recombinant yeeO protein) and negative controls (yeeO knockout samples) to properly evaluate specificity and sensitivity .
To distinguish between specific and non-specific binding, researchers should implement multiple control strategies:
Include parallel experiments with yeeO knockout strains
Perform competitive binding assays using excess recombinant yeeO protein
Use pre-immune serum (provided with some commercial antibodies) as a baseline control
Implement gradient dilution series to identify optimal signal-to-noise ratios
Perform peptide competition assays with the immunogen peptide
Compare multiple antibody lots if available
These approaches help determine the specificity threshold and minimize misinterpretation of experimental results, particularly important when working with bacterial membrane proteins that may share structural similarities .
Conjugating yeeO antibodies to oligonucleotides enables highly sensitive detection methods. The recommended approach uses strain-promoted alkyne-azide cycloaddition (Cu-free click chemistry):
Activate the antibody with dibenzocyclooctyne (DBCO) moiety
Prepare azide-modified oligonucleotides with your sequence of interest
React the DBCO-activated antibody with the azide-modified oligonucleotide
Purify the conjugate using size exclusion chromatography
Validate conjugate activity using established assays (ELISA, Western blot)
This conjugation approach provides several advantages including mild reaction conditions, no copper catalyst requirement, and minimal impact on antibody function. The resulting conjugates can be used in highly sensitive detection methods like Oligonucleotide Extension Reaction (OER) for multiplex protein detection .
Researchers can employ several complementary methods to determine binding affinity of yeeO antibodies:
Surface Plasmon Resonance (SPR): Measures real-time binding kinetics to determine kon, koff, and KD values
Bio-Layer Interferometry (BLI): Provides association/dissociation rate constants and equilibrium dissociation constants
Enzyme-Linked Immunosorbent Assay (ELISA): Using serial dilutions to generate binding curves
Flow Cytometry: With antibody titration to determine apparent KD,app values
Isothermal Titration Calorimetry (ITC): For thermodynamic parameters of binding
The resulting data should be analyzed using appropriate binding models. For most research applications, a KD,app range from 0.1 nM to 100 nM indicates high-affinity binding suitable for most applications .
For advanced imaging of yeeO in bacterial systems:
Super-resolution microscopy:
Label yeeO antibodies with bright, photostable fluorophores (Alexa Fluor 647 or similar)
Use techniques like STORM, PALM, or STED for sub-diffraction resolution imaging
Implement dual-color imaging with membrane markers to establish precise localization
Expansion microscopy:
Fix and permeabilize bacteria according to established protocols
Use yeeO antibodies conjugated to anchoring molecules
Embed in expandable polymer and physically expand the sample
Image with conventional microscopes to achieve effective super-resolution
Cryo-electron microscopy with immunogold labeling:
Conjugate yeeO antibodies to gold nanoparticles
Apply to thin-sectioned or whole-mount bacterial samples
Visualize protein localization at nanometer resolution
These approaches can reveal the precise subcellular localization of yeeO protein within bacterial membranes, providing insights into its functional role .
| Issue | Potential Causes | Solution Strategies |
|---|---|---|
| Poor IP efficiency | Insufficient antibody, inappropriate lysis conditions, protein inaccessibility | Increase antibody amount (5-10 μg), optimize lysis buffer composition, extend incubation time (overnight at 4°C) |
| High background | Insufficient washing, non-specific binding | Implement more stringent washing steps, pre-clear lysates, optimize blocking conditions |
| No detectable signal | Low expression level, epitope masking, denatured protein | Use more starting material, try alternative lysis methods, confirm target expression |
| Multiple bands | Cross-reactivity, protein degradation, post-translational modifications | Validate with knockout controls, add protease inhibitors, perform mass spectrometry validation |
| Inconsistent results | Batch variation, experimental conditions | Standardize protocols, use consistent antibody lots, implement robust controls |
For membrane proteins like yeeO, detergent selection is critical - test different detergents (Triton X-100, NP-40, digitonin) to find optimal extraction efficiency while preserving epitope accessibility .
Buffer compositions significantly impact antibody performance across applications:
ELISA:
PBS or TBS with low detergent (0.05% Tween-20)
pH 7.2-7.4 optimal for antibody-antigen interaction
BSA (1-3%) reduces non-specific binding
Western blot:
TBST/PBST with 0.1-0.5% Tween-20 for reduced background
Transfer buffer composition affects protein transfer efficiency
Blocking buffer composition critical for signal-to-noise ratio
Immunoprecipitation:
Lysis buffers need careful optimization (detergent type/concentration)
Salt concentration (150-500 mM) affects stringency
Non-ionic detergents preserve protein-protein interactions
Flow cytometry/Immunofluorescence:
Fixative selection crucial (4% PFA vs. methanol)
Permeabilization agents (0.1-0.5% Triton X-100, 0.1% saponin)
BSA or FBS (1-5%) in staining buffers reduces background
For bacterial membrane proteins like yeeO, buffer optimization is particularly important to ensure proper protein solubilization while maintaining epitope integrity .
When faced with contradictory results across different detection methods:
Systematically evaluate epitope accessibility:
Each method subjects the epitope to different conditions (denatured in WB, native in IF)
Epitope masking may occur in native conditions due to protein conformation or interactions
Consider using multiple antibodies targeting different epitopes
Assess method-specific limitations:
Western blot: Denaturation may expose hidden epitopes
IF/Flow: Fixation may alter protein structure or accessibility
IP: Detergent sensitivity may affect epitope recognition
Implement orthogonal validation:
Use genetic approaches (tagged constructs, knockouts)
Apply non-antibody methods (mass spectrometry)
Consider transcript-level analysis to complement protein studies
Design controlled experiments:
Use the same sample preparation for multiple methods
Include appropriate positive and negative controls
Quantify results across multiple experiments for statistical validity
This systematic approach can resolve apparent contradictions and yield more accurate interpretations of yeeO protein expression, localization, and function .
For multi-parameter phenotyping:
Multicolor flow cytometry:
Combine yeeO antibody detection with viability dyes and other bacterial markers
Establish compensation protocols to account for spectral overlap
Use dimensionality reduction techniques (tSNE, UMAP) for data visualization
Multiplexed imaging:
Implement cyclic immunofluorescence with antibody stripping/re-probing
Use spectrally distinct fluorophores for simultaneous detection
Combine with FISH for simultaneous protein and RNA detection
Mass cytometry (CyTOF):
Conjugate yeeO antibodies to rare-earth metals
Combine with other metal-labeled antibodies for high-dimensional analysis
Apply clustering algorithms to identify distinct bacterial subpopulations
These approaches enable correlation of yeeO expression with other bacterial characteristics like metabolic state, antibiotic resistance, or virulence factor expression .
For proximity-based interaction studies:
Proximity Ligation Assay (PLA):
Conjugate yeeO antibodies to DNA oligonucleotides
Combine with antibodies against potential interaction partners
Only when proteins are in close proximity (<40 nm) will amplifiable DNA circles form
Optimize probe concentrations, ligation conditions, and amplification parameters
FRET/BRET approaches:
Conjugate yeeO antibodies with donor fluorophores
Label potential interaction partners with acceptor fluorophores
Measure energy transfer as indication of proximity
Consider distance constraints and fluorophore orientation
Split enzyme complementation:
Conjugate yeeO antibodies to one fragment of a split reporter enzyme
Label potential interaction partners with complementary fragments
Enzymatic activity indicates proximity
These methods require careful validation and controls to distinguish specific interactions from random co-localization, particularly important in the confined space of bacterial cells .